In addition, tumor volumes of human melanoma xenografts in severe combined immunodeficiency (SCID) mice had only a marginal, non-significant response to AKB-6899 alone, suggesting that HIF-2α activation in immune cells, particularly macrophages, is likely required for the decreased tumor growth and improved survival seen in immunocompetent mice. The gene discussed is EPAS1; the disease is melanoma.